Informatics

Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors

Retrieved on: 
torsdag, maj 30, 2024
Biotechnology, Neurology, Infectious Diseases, Health, Pharmaceutical, ACT, Patient, Informatics, Kinetic Concepts, Business, CRM, New York Stock Exchange, Vanderbilt University Medical Center, Informatics Corporation of America, Research, DSM-IV codes, Division, Merck, VUMC, Health Affairs, Professor, Monroe J. Carell Jr., Hospital, Internal medicine, Knowledge, OTCQB

Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Dr. Harry Jacobson has agreed to join its Board of Directors in the coming months.

Key Points: 
  • Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Dr. Harry Jacobson has agreed to join its Board of Directors in the coming months.
  • “We are thrilled to welcome Dr. Jacobson to our Board of Directors,” said Philip J.
  • Currently, Dr. Jacobson serves on the Board of Directors of several healthcare companies from the original MedCare portfolio.
  • “I am excited to join Lobe Sciences at such a pivotal time in the company’s growth,” said Dr. Jacobson.

LabVantage Acquires SEIN Infotech South Korea to Expand Environmental Compliance Offerings and Further Growth in APAC Region

Retrieved on: 
torsdag, maj 30, 2024
Biotechnology, Technology, Environmental Policy, Health, General Health, Pharmaceutical, Other Science, Green Technology, Software, Environment, Science, Quality, LIMS, LabVantage, EHS, Safety, Informatics, Growth, Acquisition, Multimedia

This move strategically expands LabVantage's capabilities in the Asia-Pacific (APAC) region, particularly enhancing its environmental compliance offerings and enabling the company to provide an unrivaled, industry-first integrated informatics platform with EHS management solutions for the global energy and chemical industries .

Key Points: 
  • This move strategically expands LabVantage's capabilities in the Asia-Pacific (APAC) region, particularly enhancing its environmental compliance offerings and enabling the company to provide an unrivaled, industry-first integrated informatics platform with EHS management solutions for the global energy and chemical industries .
  • View the full release here: https://www.businesswire.com/news/home/20240530178403/en/
    Michel Gerlicher, President of LabVantage International (R), and Jung Moon Lee, CEO of SEIN Infotech (L), seal the acquisition with a handshake.
  • Michel Gerlicher, President of LabVantage International, stated, “It is with great pleasure that we welcome SEIN Infotech's talented team and their loyal clients into the LabVantage family.
  • The SEIN Infotech acquisition underscores LabVantage's commitment to innovation and excellence in laboratory informatics, ensuring clients receive optimal support for achieving regulatory compliance and operational safety.

NTT and NTT DATA Roar into the Indianapolis 500 with AI-powered Fan Experience

Retrieved on: 
torsdag, maj 23, 2024
Technology, Mobile, Wireless, Audio, Video, Entertainment, Events, Concerts, Apps, Applications, Artificial Intelligence, Sports, Telecommunications, Software, Motor Sports, Hardware, Data Management, Security, Knowledge, App, Informatics, Human, Television, Education, Google Play, NTT, IPad Air 2, Sport, XR, IMS, AI, Research, Social media, Pagoda, Knowledge management, NTT DATA, Mobile telephony

NTT, a leading global technology and business solutions provider, and NTT DATA continue to expand innovative use of racing data to improve fan experiences across the NTT INDYCAR SERIES , including this year’s Indianapolis 500.

Key Points: 
  • NTT, a leading global technology and business solutions provider, and NTT DATA continue to expand innovative use of racing data to improve fan experiences across the NTT INDYCAR SERIES , including this year’s Indianapolis 500.
  • NTT is the parent company of NTT DATA, and they serve together as Official Technology Partner of INDYCAR, the NTT INDYCAR SERIES, Indianapolis Motor Speedway (IMS), the Indianapolis 500, and NASCAR Brickyard weekend.
  • Through 140-plus sensors on each racecar, NTT DATA captures and analyzes more than 8 billion racing datapoints in the NTT Smart Solutions Platform.
  • Fans at the Indianapolis 500 or other events at the Indianapolis Motor Speedway can experience NTT DATA Smart Venue technology, sustainability solutions and live race data at the Pagoda command displays.

NTT and NTT DATA Roar into the Indianapolis 500 with AI-powered Fan Experience

Retrieved on: 
torsdag, maj 23, 2024
Family, Vehicle Technology, Data Management, Sports, General Automotive, Data Analytics, Other Entertainment, Technology, Apps, Applications, Consumer, Entertainment, Other Automotive, Performance & Special Interest, Motor Sports, Artificial Intelligence, Professional Services, Automotive, Women, Other Technology, Events, Concerts, Software, Men, Knowledge, App, Penske Corporation, DATA, Informatics, Organization, Human, Television, Movement, Education, Google Play, NTT, Safety, IPad Air 2, Sport, XR, IMS, AI, Research, Social media, Pagoda, Knowledge management, NTT DATA

NTT, a leading global technology and business solutions provider, and NTT DATA continue to expand innovative use of racing data to improve fan experiences across the NTT INDYCAR SERIES , including this year’s Indianapolis 500.

Key Points: 
  • NTT, a leading global technology and business solutions provider, and NTT DATA continue to expand innovative use of racing data to improve fan experiences across the NTT INDYCAR SERIES , including this year’s Indianapolis 500.
  • NTT is the parent company of NTT DATA, and they serve together as Official Technology Partner of INDYCAR, the NTT INDYCAR SERIES, Indianapolis Motor Speedway (IMS), the Indianapolis 500, and NASCAR Brickyard weekend.
  • Through 140-plus sensors on each racecar, NTT DATA captures and analyzes more than 8 billion racing data points in the NTT Smart Solutions Platform.
  • NTT Embodied Knowledge technology is being explored for future use cases including medical surgery training, coaching and fan experiences in sports.

Sapient Appoints Jonathan Usuka as Chief Business Officer

Retrieved on: 
tisdag, maj 7, 2024
Oncology, Health, Hospitals, General Health, Clinical Trials, Pharmaceutical, Biotechnology, University, Informatics, Protein, University of Pennsylvania, McKinsey & Company, NIH, AI, Princeton University, Proteomics, MD, Doctor of Philosophy, Roche, Therapy, Stanford University, Patient, Genome, MBA, Drug development, Metabolomics, Drug discovery, Analytics, Celgene, Growth

Sapient , a leading biomarker discovery organization providing at scale services for multi-omics data generation and analysis, has announced the appointment of Jonathan Usuka, PhD, MBA as Chief Business Officer, expanding its leadership team to support and further propel the company’s rapid growth.

Key Points: 
  • Sapient , a leading biomarker discovery organization providing at scale services for multi-omics data generation and analysis, has announced the appointment of Jonathan Usuka, PhD, MBA as Chief Business Officer, expanding its leadership team to support and further propel the company’s rapid growth.
  • “We are absolutely thrilled to welcome Jonathan into this critical leadership role for Sapient,” said Mo Jain, MD, PhD, Founder and CEO of Sapient.
  • Previously, Dr. Usuka was a Senior Expert at McKinsey & Company, leading their Center for Analytics and Real-world Evidence.
  • “Sapient has an amazing group of scientists and a technology approach that can revolutionize the discovery and development of novel therapeutics, and I'm honored to join in that pursuit,” said Dr. Usuka.

Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer

Retrieved on: 
måndag, maj 6, 2024
Chase Bank, University, JPMorgan Chase, Informatics, General Electric, Oak Street, Health, CVS Health, Quest Diagnostics, Information technology, Digital, Engineering, Senior, Fiserv, MBA, Oak Street Health, DGX, Moses Austin, Management

SECAUCUS, N.J., May 6, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran information technology healthcare business leader, has been named Senior Vice President and Chief Information and Digital Officer (CIDO).

Key Points: 
  • SECAUCUS, N.J., May 6, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran information technology healthcare business leader, has been named Senior Vice President and Chief Information and Digital Officer (CIDO).
  • Mr. Balakumar, based at the company's headquarters in Secaucus, N.J., is responsible for leading information technology, data informatics and digital solutions for Quest Diagnostics.
  • Prior to joining Quest, Murali was Chief Information Officer at Oak Street Health, which was acquired by CVS Health in 2023.
  • Prior to Oak Street, Murali was Chief Information Officer for Card Services at Fiserv and has also held IT leadership roles at JPMorgan Chase Bank and General Electric.

Arcturis and Oxford University Hospitals NHS Foundation Trust announce 3-year programme to deliver highly enriched Real-World Data supporting generation of evidence for the development and approval of novel cancer therapies.

Retrieved on: 
fredag, maj 3, 2024
Data Management, Biotechnology, Technology, Professional Services, Health, General Health, Oncology, Health Technology, Data Analytics, Software, Genetics, TVS, Cancer, Partnership, NHS, Real, Informatics, Health care, Research, Pharmacy, OUH, Environment, Thames Valley, Patient, Privacy, Google Images, Biomarker, Confidentiality, Medical imaging

OUH will provide Arcturis researchers with access to its deep, longitudinal anonymised oncology data within the Thames Valley and Surrey Secure Data Environment for healthcare research (TVS SDE).

Key Points: 
  • OUH will provide Arcturis researchers with access to its deep, longitudinal anonymised oncology data within the Thames Valley and Surrey Secure Data Environment for healthcare research (TVS SDE).
  • This innovative approach will facilitate access to anonymised NHS data for approved research projects within an NHS-controlled environment.
  • Kerrie Woods, Director, R&D Clinical Informatics for OUH commented:
    “Arcturis has unique expertise in integrating molecular and clinical data and curating fit-for-purpose regulatory-grade research datasets.
  • This valuable work will help to improve the quality and completeness of the data available for world class research, driving real world impact.

Ironlight Group to Create DLT Fintech Ecosystem; Former TD Bank CEO Greg Braca Named Advisor

Retrieved on: 
torsdag, maj 2, 2024
Informatics, Ecosystem, ATS, DLT, Blockchain, RWA, Workflow, Schroders, Alternative trading system, Natural Resources, FINRA, Lexical analysis, Toronto-Dominion Bank, Knowledge, Cryptocurrency

Ironlight plans a premier DLT-backed tokenization, listing, and trading ecosystem for private securities, funds, and RWA

Key Points: 
  • Ironlight plans a premier DLT-backed tokenization, listing, and trading ecosystem for private securities, funds, and RWA
    The company also named former TD Bank President and CEO Greg Braca as a strategic advisor and board member.
  • He brings 40 years of financial services experience, including TD Bank, which grew to nearly $500 billion in assets and 25,000 employees under his leadership.
  • "We're also excited that a highly accomplished leader like Greg Braca is joining the team.
  • He arrives with four decades of experience and understands the importance of DLT to the future of finance," he said.

Smart Hospital Maturity Model Expands Advisory Panel and Advances Development

Retrieved on: 
onsdag, maj 1, 2024
University, DNP, PMP, Informatics, Investment, Patient safety organization, Novant Health, Safety, Policy, Business development, MD, Publishing, Doctor of Philosophy, Human, Children's Hospital, Information technology, SVP, Senior, Nursing, MPH, RN, ViVe, Healthcare Financial Management Association, MBA, Senior advisor, MHA, HFMA, Management

ORLANDO, Fla., May 1, 2024 /PRNewswire/ -- Since the February 26, 2024, announcement at ViVE of the development of the "Smart Hospital Maturity Model," enthusiasm from across the industry has led to broader involvement to guide the initiative.

Key Points: 
  • ORLANDO, Fla., May 1, 2024 /PRNewswire/ -- Since the February 26, 2024, announcement at ViVE of the development of the "Smart Hospital Maturity Model," enthusiasm from across the industry has led to broader involvement to guide the initiative.
  • "Unlike measuring maturity of an electronic medical record implementation, defining and determining the value of a smart hospital must incorporate the vision and input beyond information technology," said Chakri Toleti, founder & CEO of care.ai.
  • "Toward that end, we are pleased to add this diverse group of healthcare leaders to the advisory panel, representing health systems, trusted industry associations and thought leadership organizations."
  • Further information and insights about the Smart Hospital Maturity Model is available through a recent podcast interview with Steve Lieber.

EDETEK to Present Keynote Presentation at 15th Clinical Trials Strategic Summit

Retrieved on: 
tisdag, april 30, 2024
Innovation, Clinical trial, CTSS, Informatics, Medical device

PRINCETON, N.J., April 30, 2024 /PRNewswire/ -- EDETEK Inc., a leading global provider of comprehensive, fully integrated platforms and services for clinical development across the biopharma, medical devices, and diagnostics industries, announced today that it will be a platinum sponsor and present 15th Clinical Trials Strategic Summit (CTSS), May 1-2, 2024, Boston, MA. Munther Baara, VP, Product Strategy & Innovation, EDETEK, Inc. will deliver a keynote presentation entitled, "Unlock Clinical Data to Guide Agile Decision Making." This presentation takes place on Wednesday, May 1 at 1:30pm ET.

Key Points: 
  • PRINCETON, N.J., April 30, 2024 /PRNewswire/ -- EDETEK Inc., a leading global provider of comprehensive, fully integrated platforms and services for clinical development across the biopharma, medical devices, and diagnostics industries, announced today that it will be a platinum sponsor and present 15th Clinical Trials Strategic Summit (CTSS), May 1-2, 2024, Boston, MA.
  • Munther Baara, VP, Product Strategy & Innovation, EDETEK, Inc. will deliver a keynote presentation entitled, "Unlock Clinical Data to Guide Agile Decision Making."
  • "In the fast-paced world of clinical trials, the ability to swiftly unlock and interpret complex data sets is crucial for agile decision-making," said Mr. Baara.
  • This presentation explores EDETEK's innovative solutions that empower sponsors to seamlessly access, analyze, and act upon clinical data.